KR100929983B1 - 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 - Google Patents
유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 Download PDFInfo
- Publication number
- KR100929983B1 KR100929983B1 KR1020090057482A KR20090057482A KR100929983B1 KR 100929983 B1 KR100929983 B1 KR 100929983B1 KR 1020090057482 A KR1020090057482 A KR 1020090057482A KR 20090057482 A KR20090057482 A KR 20090057482A KR 100929983 B1 KR100929983 B1 KR 100929983B1
- Authority
- KR
- South Korea
- Prior art keywords
- neutralization
- plate member
- waves
- ring
- carbon
- Prior art date
Links
- 238000006386 neutralization reaction Methods 0.000 title claims description 24
- 230000004913 activation Effects 0.000 title claims description 22
- 230000006641 stabilisation Effects 0.000 title claims description 6
- 238000011105 stabilization Methods 0.000 title claims description 6
- 210000004556 brain Anatomy 0.000 title description 4
- 230000001473 noxious effect Effects 0.000 title 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 34
- 230000009931 harmful effect Effects 0.000 claims abstract description 34
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229910052802 copper Inorganic materials 0.000 claims abstract description 12
- 239000010949 copper Substances 0.000 claims abstract description 12
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 11
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims abstract description 11
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 7
- 239000010936 titanium Substances 0.000 claims abstract description 7
- 230000000903 blocking effect Effects 0.000 claims description 22
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims description 14
- 229910052900 illite Inorganic materials 0.000 claims description 9
- VGIBGUSAECPPNB-UHFFFAOYSA-L nonaaluminum;magnesium;tripotassium;1,3-dioxido-2,4,5-trioxa-1,3-disilabicyclo[1.1.1]pentane;iron(2+);oxygen(2-);fluoride;hydroxide Chemical compound [OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[F-].[Mg+2].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].[K+].[Fe+2].O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2.O1[Si]2([O-])O[Si]1([O-])O2 VGIBGUSAECPPNB-UHFFFAOYSA-L 0.000 claims description 9
- 229910052613 tourmaline Inorganic materials 0.000 claims description 9
- 239000011032 tourmaline Substances 0.000 claims description 9
- 229940070527 tourmaline Drugs 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 7
- 239000012780 transparent material Substances 0.000 claims description 3
- 231100001261 hazardous Toxicity 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 11
- 150000002500 ions Chemical class 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 150000001450 anions Chemical class 0.000 description 15
- 239000003610 charcoal Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000005855 radiation Effects 0.000 description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 description 11
- 239000011707 mineral Substances 0.000 description 11
- 235000010755 mineral Nutrition 0.000 description 11
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000003462 bioceramic Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 150000001768 cations Chemical class 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 210000000467 autonomic pathway Anatomy 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000005611 electricity Effects 0.000 description 3
- 108010074605 gamma-Globulins Proteins 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 230000007420 reactivation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- MLBYBBUZURKHAW-UHFFFAOYSA-N 4-epi-Palustrinsaeure Natural products CC12CCCC(C)(C(O)=O)C1CCC1=C2CCC(C(C)C)=C1 MLBYBBUZURKHAW-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000003174 Brain Neoplasms Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 102000009025 Endorphins Human genes 0.000 description 1
- 108010049140 Endorphins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000004887 air purification Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 210000003403 autonomic nervous system Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229910052626 biotite Inorganic materials 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005674 electromagnetic induction Effects 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000005389 magnetism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000036649 mental concentration Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 150000002910 rare earth metals Chemical class 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 229910001727 uranium mineral Inorganic materials 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A44—HABERDASHERY; JEWELLERY
- A44C—PERSONAL ADORNMENTS, e.g. JEWELLERY; COINS
- A44C25/00—Miscellaneous fancy ware for personal wear, e.g. pendants, crosses, crucifixes, charms
- A44C25/001—Pendants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L9/00—Disinfection, sterilisation or deodorisation of air
- A61L9/16—Disinfection, sterilisation or deodorisation of air using physical phenomena
- A61L9/22—Ionisation
-
- G—PHYSICS
- G12—INSTRUMENT DETAILS
- G12B—CONSTRUCTIONAL DETAILS OF INSTRUMENTS, OR COMPARABLE DETAILS OF OTHER APPARATUS, NOT OTHERWISE PROVIDED FOR
- G12B17/00—Screening
- G12B17/02—Screening from electric or magnetic fields, e.g. radio waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
Abstract
Description
Claims (6)
- 삭제
- 중앙에서부터 탄소, 납, 알루미늄, 구리가 순차적으로 배열된 원형판 형상의 중앙부재(10)와; 상기 중앙부재의 상부면에 부착되는 탄소, 일라이트, 토르마린 중 어느 하나로 된 상판부재(20)와; 상기 중앙부재의 하부면에 부착되는 탄소, 일라이트, 토르마린 중 어느 하나로 된 하판부재(30)로 구성되어지되,상기 중앙부재(10)는 지름 1.5~2.0㎝, 높이 0.3~1.0㎜의 탄소원판(11) 외주연에 2~5㎜ 두께의 납링(12)이 둘러져 있으며, 상기 납링(12) 외주연으로 2~5㎜ 두께의 알루미늄링(13)이 둘러져 있고, 상기 알루미늄링(13) 외주연으로 2~5㎜ 두께의 구리링(14)이 둘러져 있으며, 상기 상판부재(20)와 상기 하판부재(30)는 지름은 상기 중앙부재(10)의 지름과 동일하고 높이는 0.3~0.1mm의 원판으로 구성되는 것을 특징으로 하는 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품.
- 제2항에 있어서,상기 하판부재(30), 중앙부재(10), 상판부재(20)가 순차적으로 수납되고 티타늄으로 된 하부케이스(50)와; 상기 상판부재(20) 상측으로 상기 하부케이스(50)를 덮고 투명 재질로 된 상부커버(40)가 더 부가되는 것을 특징으로 하는 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090057482A KR100929983B1 (ko) | 2009-06-26 | 2009-06-26 | 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090057482A KR100929983B1 (ko) | 2009-06-26 | 2009-06-26 | 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100929983B1 true KR100929983B1 (ko) | 2009-12-04 |
Family
ID=41683857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090057482A KR100929983B1 (ko) | 2009-06-26 | 2009-06-26 | 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100929983B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101101979B1 (ko) * | 2011-10-20 | 2012-01-02 | 이우상 | 유해파 차단기구 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200167054Y1 (ko) | 1998-06-29 | 2000-02-15 | 김영건 | 원적외선 방사 및 다목적 기능을 갖는 액세서리 패널 |
JP2005119084A (ja) | 2003-10-15 | 2005-05-12 | Sota Japan Kk | 積層体及びその製造方法、並びに装身具 |
JP2007244822A (ja) * | 2006-03-15 | 2007-09-27 | Eiji Sato | 体内電磁波コントロール身体装着品 |
KR100881314B1 (ko) * | 2008-09-26 | 2009-02-03 | 정은자 | 지전류 및 유해파를 차단하는 차단제품 |
-
2009
- 2009-06-26 KR KR1020090057482A patent/KR100929983B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR200167054Y1 (ko) | 1998-06-29 | 2000-02-15 | 김영건 | 원적외선 방사 및 다목적 기능을 갖는 액세서리 패널 |
JP2005119084A (ja) | 2003-10-15 | 2005-05-12 | Sota Japan Kk | 積層体及びその製造方法、並びに装身具 |
JP2007244822A (ja) * | 2006-03-15 | 2007-09-27 | Eiji Sato | 体内電磁波コントロール身体装着品 |
KR100881314B1 (ko) * | 2008-09-26 | 2009-02-03 | 정은자 | 지전류 및 유해파를 차단하는 차단제품 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101101979B1 (ko) * | 2011-10-20 | 2012-01-02 | 이우상 | 유해파 차단기구 |
WO2013058492A2 (ko) * | 2011-10-20 | 2013-04-25 | Lee Woo-Sang | 유해파 차단기구 |
WO2013058492A3 (ko) * | 2011-10-20 | 2013-06-20 | Lee Woo-Sang | 유해파 차단기구 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR200410065Y1 (ko) | 복합 기능 자석 밴드 | |
KR101937764B1 (ko) | 돔형 사우나 장치 | |
KR101237700B1 (ko) | 탈취·제습·항균기능을 갖는 다기능성의 기공성 구상 소성체 | |
KR20010103109A (ko) | 기능성합성수지의 제조방법 | |
KR200446801Y1 (ko) | 기능성 수지 자석이 구비된 복합 기능 건강 밴드 | |
KR100929983B1 (ko) | 유해파 차단(중화), 뇌파안정 및 생체리듬 활성화 증강 장신구 내장재 제품 | |
KR100881314B1 (ko) | 지전류 및 유해파를 차단하는 차단제품 | |
KR101703479B1 (ko) | 페그마타이트 등을 포함한 직물발열체, 난방커튼 및 이의 제조방법 | |
CN201341652Y (zh) | 多功能保健床垫 | |
KR100917318B1 (ko) | 유해파 차단구 | |
KR20110002114A (ko) | 음이온과 원적외선이 발생하고 지전류 및 유해파를 차단(중화)하는 제품 | |
KR100825126B1 (ko) | 자력, 음이온 및 원적외선이 방출되는 의료용 이온 단자제조방법 | |
KR200326158Y1 (ko) | 탄소성형체 패널을 이용한 침대 | |
KR100894614B1 (ko) | 광물혼합물 및 세라믹판을 이용한 특정합성전자기력파 온열기구의 제조방법 및 상기 제조방법에 의해 제조된 온열기구 | |
KR200414803Y1 (ko) | 자석과 세라믹을 포함하는 건강밴드 | |
KR102469919B1 (ko) | 영구자석을 이용한 고효율의 건강증진용 복합기능 자석조립체 제조방법 | |
KR20180067480A (ko) | 천연석분말이 혼합된 접착혼합물층이 하부에 형성된 핫픽스 | |
KR20130056366A (ko) | 옥을 함유한 난방필름 | |
KR102367117B1 (ko) | 전자파 흡수 및 원적외선 방사시트 | |
KR101937297B1 (ko) | 손목시계용 건강 밴드의 제조방법 및 이에 의해 제조된 손목시계용 건강 밴드 | |
KR20180118909A (ko) | 원적외선과 음이온이 방출되는 조성물 | |
KR100534646B1 (ko) | 음이온과 원적외선이 방출되도록 한 장신구 가공방법 및그에 따른 장신구 제품 | |
KR20110100390A (ko) | 빅터 건강 밴드 | |
KR20020070205A (ko) | 기능성 건강 보조용 책상 및 그 제조방법 | |
KR100348158B1 (ko) | 음이온과 원적외선 방사물질의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130524 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131126 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141126 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20160826 Year of fee payment: 7 |
|
R401 | Registration of restoration | ||
FPAY | Annual fee payment |
Payment date: 20161129 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180530 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181126 Year of fee payment: 10 |